SLS
SELLAS Life Sciences Group, Inc. SEC filings
Every EDGAR filing for SELLAS Life Sciences Group, Inc. (SLS), newest first, with AI summaries and stories.
- Ticker
- SLS
- CIK
- 1390478
- Latest filing
- Aug 11
Next: earnings expected ~Nov 12 · 10-Q expected ~Nov 12 (deadline Nov 16)
Filings
Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.
ROUTINE8-KSELLAS Life Sciences Group, Inc.SLSLIVE NOTABLE10-QSELLAS Life Sciences Group, Inc.SLSLIVE ROUTINESCHEDULE 13GSELLAS Life Sciences Group, Inc.SLSLIVE Ownership stake disclosure by STATE STREET CORP
STATE STREET CORP, filed by
ROUTINESCHEDULE 13GSELLAS Life Sciences Group, Inc.SLSLIVE Ownership stake disclosure by VANGUARD CAPITAL MANAGEMENT LLC
VANGUARD CAPITAL MANAGEMENT LLC, filed by
ROUTINE8-KSELLAS Life Sciences Group, Inc.SLSLIVE ROUTINE8-KSELLAS Life Sciences Group, Inc.SLSLIVE ROUTINE4SELLAS Life Sciences Group, Inc.SLSLIVE Angelos M. Stergiou, insider filing for SLS
Angelos M. Stergiou, reporting
ROUTINE8-KSELLAS Life Sciences Group, Inc.SLSLIVE ROUTINES-8SELLAS Life Sciences Group, Inc.SLSLIVE ROUTINE8-KSELLAS Life Sciences Group, Inc.SLSLIVE ROUTINE8-KSELLAS Life Sciences Group, Inc.SLSLIVE NOTABLE10-QSELLAS Life Sciences Group, Inc.SLSLIVE ROUTINESCHEDULE 13G/ASELLAS Life Sciences Group, Inc.SLSLIVE Ownership stake disclosure by BlackRock, Inc. (amended)
BlackRock, Inc., filed by
ROUTINEARSSELLAS Life Sciences Group, Inc.SLSLIVE ROUTINEDEF 14ASELLAS Life Sciences Group, Inc.SLSLIVE ROUTINEDEFA14ASELLAS Life Sciences Group, Inc.SLSLIVE ROUTINESCHEDULE 13G/ASELLAS Life Sciences Group, Inc.SLSLIVE Ownership stake disclosure by VANGUARD GROUP INC (amended)
VANGUARD GROUP INC, filed by
ROUTINES-3ASRSELLAS Life Sciences Group, Inc.SLSLIVE ROUTINE8-KSELLAS Life Sciences Group, Inc.SLSLIVE NOTABLE10-KSELLAS Life Sciences Group, Inc.SLSLIVE ROUTINE8-KSELLAS Life Sciences Group, Inc.SLSLIVE ROUTINESCHEDULE 13G/ASELLAS Life Sciences Group, Inc.SLSLIVE Ownership stake disclosure by Anson Funds Management LP (amended)
Anson Funds Management LP, filed by
ROUTINESCHEDULE 13G/ASELLAS Life Sciences Group, Inc.SLSLIVE Ownership stake disclosure by HIGHBRIDGE CAPITAL MANAGEMENT LLC (amended)
HIGHBRIDGE CAPITAL MANAGEMENT LLC, filed by
ROUTINE4SELLAS Life Sciences Group, Inc.SLSLIVE 7 insider filings
John Varian, insider filing for SLS
Show all 7
- 4Insider filing for SLS
- 4Insider filing for SLS
- 4Insider filing for SLS
- 4Insider filing for SLS
- 4Insider filing for SLS
- 4Insider filing for SLS
- 4Insider filing for SLS
John Varian, reporting
ROUTINE8-KSELLAS Life Sciences Group, Inc.SLSLIVE ROUTINE4SELLAS Life Sciences Group, Inc.SLSLIVE 3 insider filings
Dragan Cicic, insider filing for SLS
Show all 3
- 4Insider filing for SLS
- 4Insider filing for SLS
- 4Insider filing for SLS
Dragan Cicic, reporting
ROUTINEEFFECTSELLAS Life Sciences Group, Inc.SLSLIVE ROUTINE4SELLAS Life Sciences Group, Inc.SLSLIVE SELLAS Life Sciences Group, Inc. - Insider ownership filing (4)
- Insider ownership filing (4)
- Reports beneficial ownership changes
Katherine Bach Kalin, reporting
ROUTINESCHEDULE 13GSELLAS Life Sciences Group, Inc.SLSLIVE Ownership stake disclosure by Anson Funds Management LP
Anson Funds Management LP, filed by
ROUTINE8-KSELLAS Life Sciences Group, Inc.SLSLIVE NOTABLE10-QSELLAS Life Sciences Group, Inc.SLSLIVE